Premawardhana L D, Parkes A B, Ammari F, John R, Darke C, Adams H, Lazarus J H
Department of Medicine, University of Wales College of Medicine, Cardiff, United Kingdom.
J Clin Endocrinol Metab. 2000 Jan;85(1):71-5. doi: 10.1210/jcem.85.1.6227.
Postpartum thyroid dysfunction (PPTD) occurs in 5% of women, with hypothyroidism developing in 23% of these after 3-5 yr. We have determined the prognostic significance of thyroid peroxidase antibody (TPOAb), thyroid ultrasound morphology (U/S), human leukocyte antigen haplotype, and postpartum thyroid status on the development of thyroid dysfunction 77-81 months after PPTD. Ninety-eight TPOAb-positive [48 who had developed PPTD (group 1) and 50 without PPTD (group 2)] and 70 TPOAb-negative (group 3) women (derived from 145 TPOAb-positive and 229 TPOAb-negative cohorts at the index pregnancy), with comparable ages, parity, pregnancies after index pregnancy, and follow-up duration, were studied. Thyroid dysfunction occurred in 46% of group 1 vs. 4% of group 2 (P<0.001) and 24.5% of groups 1 and 2 vs. 1.4% of group 3 (P<0.001). Factors predictive of thyroid dysfunction included a hypothyroid form of PPTD, TSH more than 20 mU/L, and higher TPOAb levels (213.8 kIU/L in group 1 vs. 131.8 kIU/L in group 2; P<0.002) during the postpartum period. Although TPOAb was higher in group 1 than in group 2 at follow-up (166 vs. 97.7 kIU/L; P<0.03), there was no significant fall in TPOAb levels within either group during the period of follow-up. The prevalence of ultrasound hypoechogenicity was higher in group 1 than in group 2 at follow-up (76% vs. 52%; P<0.006), but U/S improved in 62.5% of group 1 during the period of follow-up. Human leukocyte antigen DR10 was lower in those who developed late thyroid dysfunction. These data, representing the longest follow-up of PPTD women, clearly show that the hypothyroid form of PPTD, high TPOAb levels, and a hypoechogenic U/S pattern lead to a high risk (relative risk, 32) of long term thyroid dysfunction. This compares with a relative risk of 12.9 for TPOAb- and PPTD-positive women, who remained euthyroid at the end of the first postpartum year, and 2.8 for TPOAb-positive but PPTD-negative women, all compared to TPOAb-negative women. Therefore, long term surveillance of TPOAb- and PPTD-positive women (group 1) is indicated.
产后甲状腺功能障碍(PPTD)在5%的女性中发生,其中23%在3 - 5年后出现甲状腺功能减退。我们已经确定了甲状腺过氧化物酶抗体(TPOAb)、甲状腺超声形态(U/S)、人类白细胞抗原单倍型以及产后甲状腺状态对PPTD后77 - 81个月甲状腺功能障碍发生的预后意义。研究了98例TPOAb阳性[48例发生PPTD的女性(第1组)和50例未发生PPTD的女性(第2组)]以及70例TPOAb阴性的女性(第3组)(这些女性来自于首次妊娠时145例TPOAb阳性和229例TPOAb阴性的队列),她们在年龄、产次、首次妊娠后的妊娠次数以及随访时间方面具有可比性。第1组中46%发生了甲状腺功能障碍,而第2组为4%(P<0.001),第1组和第2组合计24.5%发生甲状腺功能障碍,而第3组为1.4%(P<0.001)。预测甲状腺功能障碍的因素包括PPTD的甲状腺功能减退形式、产后促甲状腺激素(TSH)高于20 mU/L以及更高的TPOAb水平(第1组为213.8 kIU/L,第2组为131.8 kIU/L;P<0.002)。尽管随访时第1组的TPOAb高于第2组(166 vs. 97.7 kIU/L;P<0.03),但在随访期间两组内TPOAb水平均无显著下降。随访时第1组超声低回声的发生率高于第2组(76% vs. 52%;P<0.006),但随访期间第1组中62.5%的患者超声表现有所改善。发生晚期甲状腺功能障碍的患者人类白细胞抗原DR10较低。这些数据是对PPTD女性最长时间的随访结果,清楚地表明PPTD的甲状腺功能减退形式、高TPOAb水平以及超声低回声模式会导致长期甲状腺功能障碍的高风险(相对风险为32)。与之相比,产后第一年末仍甲状腺功能正常的TPOAb和PPTD阳性女性的相对风险为12.9,TPOAb阳性但PPTD阴性女性的相对风险为2.8,所有这些均与TPOAb阴性女性相比。因此,建议对TPOAb和PPTD阳性女性(第1组)进行长期监测。